[Form 4] PetMed Express, Inc. Insider Trading Activity

Rhea-AI Filing Summary

PetMed Express (PETS) Form 4 filing: On 18 Jul 2025, 10% owner Silvercape Investments Ltd purchased 17,565 common shares at $3.23 each (≈$56.7 k). The move raises its directly held stake to 2,360,496 shares. No sales or derivative transactions were disclosed. While the add-on represents only ~0.7% of the owner’s position, continued buying from a >10% holder can signal confidence without materially altering the share count or control position.

Positive

• Insider accumulation: 10% owner Silvercape Investments bought 17,565 PETS shares, increasing its direct stake to 2.36 m shares.

Negative

• None.

Insights

Securities Analyst

TL;DR: Minor insider buy (~$57 k) nudges a 10% holder’s stake higher; sentiment positive but market impact limited.

The transaction is small relative to Silvercape’s existing 2.36 m-share position yet continues a pattern of ownership accumulation, often interpreted as a vote of confidence. However, the dollar value and percentage increase (<1%) are immaterial to float or valuation models, so I view the filing as neutral-to-slightly positive for sentiment rather than a catalyst for price movement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Silvercape Investments Ltd

(Last) (First) (Middle)

C/O TRIDENT TRUST COMPANY (CAYMAN)

LIMITED,FOURTH FLOOR, ONE CAPITAL PLACE

(Street)

GEORGE TOWN E9 KY1-1103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001	07/18/2025		P		17,565	A	$3.23	2,360,496	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Peter Kennedy	07/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for PETS?

The reporting person is Silvercape Investments Ltd, a 10% owner of PetMed Express.

How many PetMed Express shares were purchased?

Silvercape acquired 17,565 common shares.

What was the purchase price per share?

The filing shows a purchase price of $3.23 per share.

What is Silvercape’s total ownership after the transaction?

Its directly held position increased to 2,360,496 PETS shares.

Were any derivative securities involved?

No. The Form 4 reports no derivative transactions.

Is the transaction material to PetMed Express?

Given the small size (~0.7% of Silvercape's stake), it is not expected to materially impact PETS’s share structure.